Received: 9 August 2021
Revised: 12 August 2021
Accepted: 17 August 2021
First Online: 30 September 2021
Change Date: 19 January 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/S41433-021-01913-3
: MP: Nothing to disclose. LT: Nothing to disclose. VC: Advisory Board Member: Alcon, Roche, Bayer, Novartis; Grants: Bayer, Novartis—unrelated to this study. PK: Consultant; Novartis, Bayer, Regeneron, Kanghong, Allergan, RegenxBio—unrelated to this study. MB: Research funds; Pendopharm, Bioventus, Acumed—unrelated to this study.
Free to read: This content has been made available to all.